The Latest Breaking News from ADHD

The FDA approved an expanded indication for Supernus Pharmaceuticals Inc's (NASDAQ:SUPN) Qelbree (viloxazine extended-release capsules) for attention deficit hyperactivity disorder (ADHD) in adult patients aged 18 and older. The FDA has now approved Qelbree for ADHD in children (starting at age 6), adolescents, and adults. Qelbree is a novel non-stimulant taken once daily for…

Self-harm – physically hurting yourself – is common in young people, affecting about one in five teens by the age of 18.

Tony Lloyd, CEO of ADHD Foundation, discusses core symptoms and how to seek specialist help

In this edition of Inverse Daily, learn about Frederick Law Olmsted, misconceptions about ADHD, the AX-1 mission return, and more.

These illogical tests have contributed to some of the poorest mental health outcomes in the world, says Guardian columnist George Monbiot

ADHD doesn't disappear in adulthood. In fact, according to psychiatrists and advocates, there are a number of misconceptions about adult ADHD that can make living with the condition harder than it should be.

The NHS is currently trialling new ways to cut waiting times

The NHS is trialling new ways to cut waiting times using a monitoring device to hasten diagnosis of irregular heart rhythms

Operations can have cognitive side-effects, particularly in the over-65s but also in the very young, where anaesthetic has been linked to ADHD. How can science minimise the danger?

This was the response when the actor famously left Downton Abbey at its height, fearful of being typecast as a floppy-haired aristo. Now based in LA, he’s starring in everything from comedy and horror to a new series about Watergate

NHS patients in England have a right to choose their service provider, including some private hospitals